Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
927 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Any one offer insight about the potential of GILD? It just has an AIDS drug approved by FDA.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
927So Anthem is restricting reimbursement of axicabtagene to patients who meet the tuck-November 9
926i try to follow jacob's missives too, but i agree that was pretty weak analymopgcw-August 30
925EPVantage with a pretty levelheaded take on the pros and cons of the KITE buyouttuck-August 30
924On watch for clear above 67.14. [graphic]hollyhunter-June 5
923Well, I am also holding for now, due to coming Bictegravir P3 data, May-end/midMiljenko Zuanic-May 16
922fwiw, I am still holding for the long haul. if it dips to $60, i will add sharemopgcw-May 15
921From WP article: <Through its Medicaid program, Louisiana covered Sovaldi andMiljenko Zuanic1May 11
920 gilead & U.S. Code Section 1498: a cautionary tale perhaps? washingtonsoftware salesperson-May 11
919I have no idea what to do with my, relative large, GILD holding? Sell it with loMiljenko Zuanic-May 11
918That priority review voucher could come in handy should they buy a late stage drmore100-February 22
917This stock is giving me flashbacks to when I owned CVX. No one made $$ panic selmore1001February 15
916This week we find out if we are going to the 50s or 80s all eyes on HIV. Needs tmore100-February 13
915I concur. the price issue may be sidetracked briefly, but it will not go away. mopgcw-11/9/2016
914Regardless failure of Pro 61 (and today broad bios gain), I do think and believeMiljenko Zuanic-11/9/2016
913REGN too, next year growth will whole SECTOR (more or less) is at PMiljenko Zuanic111/2/2016
912i conur. they are at a pivot point and the internal allocation of capital needsmopgcw-11/2/2016
911GILD in TROUBLE? It is obvious that to survive (as entity) GILD need to expand Miljenko Zuanic-11/1/2016
910Why not? Waste another 2 years for P2b? IF! If not....did not loseMiljenko Zuanic-10/20/2016
909If we knew the answer, we would probably know why AGN paid a 500% premium to acqDewDiligence_on_SI-10/20/2016
908I know i am science limited, but why are they moving the NASH to p3? mopgcw-10/20/2016
907GILD dipping into bsAb, field of the next col-deal. Zuanic-7/8/2016
906 Gilead escapes liability in hepatitis C patent fight with Merck Wong-6/6/2016
905Did Roche/GNE delayed SC Rituxan formulation? Better question is; Which Comp &qMiljenko Zuanic-5/31/2016
904GILD's TAF scam: siliconinvestor.comDewDiligence_on_SI15/29/2016
903The company that Gilead should consider buying right now So what should Gilead puborectalis-2/7/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.